NutriBand (NTRB) Total Debt (2016 - 2026)

NutriBand's (NTRB) quarterly Total Debt came in at $35861.0 in Q1 2026, down 38.39% year-on-year from $58205.0 in Q1 2025, and down 13.8% quarter-over-quarter from $41603.0 in Q4 2025.

NutriBand (NTRB) Total Debt (2016 - 2026) Analysis & Trends

NutriBand has disclosed Total Debt across 11 years of filings, most recently posting $35861.0 for Q1 2026.

  • Total Debt for Q1 2026 came in at $35861.0, down 38.39% year-over-year; the trailing twelve-month figure through Jan 2026 was $35861.0 (down 38.39% YoY), and the FY2026 annual result was $35861.0, down 38.39% from the prior year.
  • Total Debt came in at $35861.0 for Q1 2026 at NutriBand, down from $41603.0 in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $115749.0 in Q2 2022 to a low of $35861.0 in Q1 2026.
  • The 5-year median for Total Debt is $79826.0 (2024), against an average of $78364.5.
  • Across the five-year window, Total Debt rose 7.1% in 2022 and tumbled 38.39% in 2026, its largest moves.
  • NutriBand's Total Debt stood at $105512.0 in 2022, then retreated by 19.34% to $85101.0 in 2023, then slipped by 25.13% to $63717.0 in 2024, then sank by 34.71% to $41603.0 in 2025, then declined by 13.8% to $35861.0 in 2026.
  • The last three Total Debt figures came in at $35861.0 (Q1 2026), $41603.0 (Q4 2025), and $47290.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 319.10 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn -
9 Abivax 94.37 Bn 94.37 Bn - -
10 NutriBand 41.91 Mn 37.33 Mn 88,941.00 35,861.00

Historic Data

Download Data
DateValue
Jan 31, 2026 35,861.00
Oct 31, 2025 41,603.00
Jul 31, 2025 47,290.00
Apr 30, 2025 52,632.00
Jan 31, 2025 58,205.00
Oct 31, 2024 63,717.00
Jul 31, 2024 69,133.00
Apr 30, 2024 74,509.00
Jan 31, 2024 79,826.00
Oct 31, 2023 85,101.00
Jul 31, 2023 90,264.00
Apr 30, 2023 95,429.00
Jan 31, 2023 100,497.00
Oct 31, 2022 105,512.00
Jul 31, 2022 115,749.00
Apr 30, 2022 115,749.00
Jan 31, 2022 101,119.00
Oct 31, 2021 104,601.00
Jul 31, 2021 108,077.00
Apr 30, 2021 111,613.00